Keith Di Petrillo
About Keith Di Petrillo
Keith Di Petrillo is the Scientific Associate Director of Discovery Toxicology at Bristol Myers Squibb, with extensive experience in pharmacology, toxicology, and genetics.
Current Position at Bristol Myers Squibb
Keith Di Petrillo serves as the Scientific Associate Director of Discovery Toxicology at Bristol Myers Squibb, based in New Jersey, United States. In this capacity, he plays a crucial role in leading and overseeing toxicology assessments within the drug discovery process. His work involves guiding high-performing teams to identify and advance lead compounds into clinical trials, ensuring the safety and efficacy of new therapeutics.
Previous Roles at Novartis Institutes for BioMedical Research
Keith Di Petrillo has an extensive history with Novartis Institutes for BioMedical Research (NIBR). He served as the Director of Translational Safety In Vivo Models from 2018 to 2020 in East Hanover, NJ, where he led teams to develop and utilize animal models for safety assessments. Prior to that, Di Petrillo was a Senior Investigator I at NIBR from 2005 to 2015, focusing on various aspects of drug discovery and translational medicine.
Tenure at Insmed Incorporated
From 2016 to 2018, Keith Di Petrillo held the position of Director, Discovery Pharmacology at Insmed Incorporated in Bridgewater, NJ. During his tenure, he was responsible for leading research efforts in pharmacology, contributing to the discovery and development of new therapeutic agents. His work primarily involved small molecules and biologic drug discovery.
Academic Background and Early Career
Keith Di Petrillo's academic journey began at the University of Rhode Island, where he earned a BS in Pharmacy between 1993 and 1998. He then pursued a PhD in Pharmacology from Dartmouth Medical School, studying from 1998 to 2002. Postdoctoral research continued at The Jackson Laboratory in Bar Harbor, ME from 2002 to 2005, where he developed a foundation in genetics and animal models. These academic and early career experiences have significantly contributed to his expertise in pharmacology, toxicology, and genetics.
Specialization and Research Focus
Keith Di Petrillo specializes in a wide array of disease areas including cardiovascular, renal, metabolism, immunology, pulmonary, and oncology diseases. His research spans both small molecule and biologic drug discovery, utilizing rodent, dog, and primate animal models. This expertise allows him to bridge toxicology with pharmacological research, driving the identification and validation of new therapeutic compounds.